Jones Financial Companies
AMRX icon

Jones Financial Companies’s Amneal Pharmaceuticals AMRX Stock Holding History

Jones Financial Companies’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
110,479
+56,157
+103% +$770K ﹤0.01% 1604
2026
Q1 		$644K Buy
54,322
+54,170
+35,638% +$727K ﹤0.01% 1920
2025
Q4 		$1.92K Buy
152
+102
+204% +$1.17K ﹤0.01% 3828
2025
Q3 		$488 Hold
50
– – ﹤0.01% 4039
2025
Q2 		$407 Hold
50
– – ﹤0.01% 3832
2025
Q1 		$414 Buy
+50
New +$417 ﹤0.01% 3534

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jones Financial Companies's AMRX Position: Q2 2026 in Review

Jones Financial Companies increased its Amneal Pharmaceuticals (AMRX) stake by 103% in Q2 2026, buying an estimated $770K and bringing the position to 110,479 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Jones Financial Companies first reported a position in AMRX in Q1 2025 and has held it in 6 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Jones Financial Companies held 110,479 shares of Amneal Pharmaceuticals worth $1.9M as of Q2 2026.
  • Jones Financial Companies bought 56,157 Amneal Pharmaceuticals shares in Q2 2026, an estimated $770K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1604 holding.
  • Jones Financial Companies first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.